Clinical trial
A Multicenter Cohort Study of the Short and Long-term Safety of Micafungin and Other Parenteral Antifungal Agents
NCT01686607 is registered in ClinicalTrials.gov with Astellas Pharma Europe B.V. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter Cohort Study of the Short and Long-term Safety of Micafungin and Other Parenteral Antifungal Agents
- Lead sponsor
- Astellas Pharma Europe B.V.
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 1, 2012
- Completion date
- April 30, 2018
- Enrollment
- 40,110 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
systemic fungal infections